222 related articles for article (PubMed ID: 30525278)
1. Zerumbone, a cyclic sesquiterpene, exerts antimitotic activity in HeLa cells through tubulin binding and exhibits synergistic activity with vinblastine and paclitaxel.
Ashraf SM; Sebastian J; Rathinasamy K
Cell Prolif; 2019 Mar; 52(2):e12558. PubMed ID: 30525278
[TBL] [Abstract][Full Text] [Related]
2. Indirubin, a bis-indole alkaloid binds to tubulin and exhibits antimitotic activity against HeLa cells in synergism with vinblastine.
Mohan L; Raghav D; Ashraf SM; Sebastian J; Rathinasamy K
Biomed Pharmacother; 2018 Sep; 105():506-517. PubMed ID: 29883946
[TBL] [Abstract][Full Text] [Related]
3. Griseofulvin stabilizes microtubule dynamics, activates p53 and inhibits the proliferation of MCF-7 cells synergistically with vinblastine.
Rathinasamy K; Jindal B; Asthana J; Singh P; Balaji PV; Panda D
BMC Cancer; 2010 May; 10():213. PubMed ID: 20482847
[TBL] [Abstract][Full Text] [Related]
4. Sertaconazole induced toxicity in HeLa cells through mitotic arrest and inhibition of microtubule assembly.
Sebastian J; Rathinasamy K
Naunyn Schmiedebergs Arch Pharmacol; 2021 Jun; 394(6):1231-1249. PubMed ID: 33620548
[TBL] [Abstract][Full Text] [Related]
5. Securinine induces mitotic block in cancer cells by binding to tubulin and inhibiting microtubule assembly: A possible mechanistic basis for its anticancer activity.
Ashraf SM; Mahanty S; Rathinasamy K
Life Sci; 2021 Dec; 287():120105. PubMed ID: 34756929
[TBL] [Abstract][Full Text] [Related]
6. Berberine Induces Toxicity in HeLa Cells through Perturbation of Microtubule Polymerization by Binding to Tubulin at a Unique Site.
Raghav D; Ashraf SM; Mohan L; Rathinasamy K
Biochemistry; 2017 May; 56(20):2594-2611. PubMed ID: 28459539
[TBL] [Abstract][Full Text] [Related]
7. Zerumbone, a ginger sesquiterpene, induces apoptosis and autophagy in human hormone-refractory prostate cancers through tubulin binding and crosstalk between endoplasmic reticulum stress and mitochondrial insult.
Chan ML; Liang JW; Hsu LC; Chang WL; Lee SS; Guh JH
Naunyn Schmiedebergs Arch Pharmacol; 2015 Nov; 388(11):1223-36. PubMed ID: 26246051
[TBL] [Abstract][Full Text] [Related]
8. Selective Inhibition of Spindle Microtubules by a Tubulin-Binding Quinazoline Derivative.
Sawada JI; Ishii H; Matsuno K; Sato M; Suzuki Y; Asai A
Mol Pharmacol; 2019 Nov; 96(5):609-618. PubMed ID: 31471455
[TBL] [Abstract][Full Text] [Related]
9. 6α-Acetoxyanopterine: A Novel Structure Class of Mitotic Inhibitor Disrupting Microtubule Dynamics in Prostate Cancer Cells.
Levrier C; Sadowski MC; Rockstroh A; Gabrielli B; Kavallaris M; Lehman M; Davis RA; Nelson CC
Mol Cancer Ther; 2017 Jan; 16(1):3-15. PubMed ID: 27760837
[TBL] [Abstract][Full Text] [Related]
10. The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth.
Jordan MA; Kamath K; Manna T; Okouneva T; Miller HP; Davis C; Littlefield BA; Wilson L
Mol Cancer Ther; 2005 Jul; 4(7):1086-95. PubMed ID: 16020666
[TBL] [Abstract][Full Text] [Related]
11. Microtubule-Targeting Agents: Strategies To Hijack the Cytoskeleton.
Steinmetz MO; Prota AE
Trends Cell Biol; 2018 Oct; 28(10):776-792. PubMed ID: 29871823
[TBL] [Abstract][Full Text] [Related]
12. Stathmin potentiates vinflunine and inhibits Paclitaxel activity.
Malesinski S; Tsvetkov PO; Kruczynski A; Peyrot V; Devred F
PLoS One; 2015; 10(6):e0128704. PubMed ID: 26030092
[TBL] [Abstract][Full Text] [Related]
13. Resistance to microtubule-targeted cytotoxins in a K562 leukemia cell variant associated with altered tubulin expression and polymerization.
Dumontet C; Jaffrezou JP; Tsuchiya E; Duran GE; Chen KG; Derry WB; Wilson L; Jordan MA; Sikic BI
Bull Cancer; 2004 May; 91(5):E81-112. PubMed ID: 15568225
[TBL] [Abstract][Full Text] [Related]
14. Cancer cells acquire mitotic drug resistance properties through beta I-tubulin mutations and alterations in the expression of beta-tubulin isotypes.
Cheung CH; Wu SY; Lee TR; Chang CY; Wu JS; Hsieh HP; Chang JY
PLoS One; 2010 Sep; 5(9):e12564. PubMed ID: 20838440
[TBL] [Abstract][Full Text] [Related]
15. Zerumbone inhibits growth of hormone refractory prostate cancer cells by inhibiting JAK2/STAT3 pathway and increases paclitaxel sensitivity.
Jorvig JE; Chakraborty A
Anticancer Drugs; 2015 Feb; 26(2):160-6. PubMed ID: 25243457
[TBL] [Abstract][Full Text] [Related]
16. Combinations of paclitaxel and vinblastine and their effects on tubulin polymerization and cellular cytotoxicity: characterization of a synergistic schedule.
Giannakakou P; Villalba L; Li H; Poruchynsky M; Fojo T
Int J Cancer; 1998 Jan; 75(1):57-63. PubMed ID: 9426691
[TBL] [Abstract][Full Text] [Related]
17. Benomyl and colchicine synergistically inhibit cell proliferation and mitosis: evidence of distinct binding sites for these agents in tubulin.
Clément MJ; Rathinasamy K; Adjadj E; Toma F; Curmi PA; Panda D
Biochemistry; 2008 Dec; 47(49):13016-25. PubMed ID: 19049291
[TBL] [Abstract][Full Text] [Related]
18. LU103793 (NSC D-669356): a synthetic peptide that interacts with microtubules and inhibits mitosis.
de Arruda M; Cocchiaro CA; Nelson CM; Grinnell CM; Janssen B; Haupt A; Barlozzari T
Cancer Res; 1995 Jul; 55(14):3085-92. PubMed ID: 7606731
[TBL] [Abstract][Full Text] [Related]
19. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
[TBL] [Abstract][Full Text] [Related]
20. DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells.
Podolski-Renić A; Banković J; Dinić J; Ríos-Luci C; Fernandes MX; Ortega N; Kovačević-Grujičić N; Martín VS; Padrón JM; Pešić M
Eur J Pharm Sci; 2017 Jul; 105():159-168. PubMed ID: 28502672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
